Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STP0404 in Adults With HIV-1 Infection
NCT05869643Phase 2Completed
- Sponsor
- ST Pharm
- Start
- May 2023
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pirmitegravir in human immunodeficiency virus infection (HIV), sponsored by ST Pharm. Started May 2023; status: completed.
02
Drugs
pirmitegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT05869643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05869643.